NUCLIDIUM Closes CHF 105M Series B — Advancing Copper-Based Radiotheranostics into Clinical Proof-of-Concept 5/27/2026 Category:
Angelini Ventures Invests in Hypervision Surgical's £17M Series A to Advance Hyperspectral Imaging in Surgery 4/29/2026 Category: INVESTMENTS
Laigo Bio raises €11.5M: a strategic investment in paradigm-shifting science through our partnership with Argobio 12/10/2025 Category: INVESTMENTS
Angelini Ventures and the European Investment Bank launch €150 Million partnership to scale European healthcare innovation 12/2/2025 Category:
Angelini Ventures